Literature DB >> 1804025

Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate.

N A Hodges1, C A Gordon.   

Abstract

Pseudomonas aeruginosa-derived alginate but no other neutral and negatively charged polysaccharides protected mucoid and nonmucoid strains of that organism against ciprofloxacin, gentamicin, ticarcillin, and ceftazidime. Data indicate that alginate has an intrinsic protective effect which is independent of diffusion, charge, or biofilm phenomena.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1804025      PMCID： PMC245405          DOI： 10.1128/AAC.35.11.2450

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.

Authors:  J R Govan; J A Fyfe
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

2.  Reduced susceptibility of a mucoid strain of Pseudomonas aeruginosa to lysis by ticarcillin and piperacillin.

Authors:  N Bolister; M Basker; N Hodges; C Marriott
Journal:  J Antimicrob Chemother       Date:  1989-10       Impact factor: 5.790

3.  The inhibitory effect of sodium alginate on antibiotic activity against mucoid and non-mucoid strains of Pseudomonas aeruginosa.

Authors:  R S Baltimore; A S Cross; A S Dobek
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

4.  Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents.

Authors:  M R Brown; P Williams
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

Review 5.  Bacterial biofilms in nature and disease.

Authors:  J W Costerton; K J Cheng; G G Geesey; T I Ladd; J C Nickel; M Dasgupta; T J Marrie
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

6.  Antibiotic penetration through bacterial capsules and exopolysaccharides.

Authors:  M P Slack; W W Nichols
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

7.  The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.

Authors:  W W Nichols; M J Evans; M P Slack; H L Walmsley
Journal:  J Gen Microbiol       Date:  1989-05

8.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

9.  Inhibition of tobramycin diffusion by binding to alginate.

Authors:  W W Nichols; S M Dorrington; M P Slack; H L Walmsley
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

10.  Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa.

Authors:  C A Gordon; N A Hodges; C Marriott
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790
View more
  22 in total

1.  Study of the response of a biofilm bacterial community to UV radiation.

Authors:  M O Elasri; R V Miller
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

2.  Interactions between biocide cationic agents and bacterial biofilms.

Authors:  C Campanac; L Pineau; A Payard; G Baziard-Mouysset; C Roques
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.

Authors:  J D Vrany; P S Stewart; P A Suci
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  M Manduru; L B Mihm; R L White; L V Friedrich; P A Flume; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.

Authors:  Ariane Khaledi; Monika Schniederjans; Sarah Pohl; Roman Rainer; Ulrich Bodenhofer; Boyang Xia; Frank Klawonn; Sebastian Bruchmann; Matthias Preusse; Denitsa Eckweiler; Andreas Dötsch; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model.

Authors:  D P Nicolau; M A Banevicius; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

7.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 8.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

9.  A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface.

Authors:  P Wood; M Jones; M Bhakoo; P Gilbert
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

10.  Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.

Authors:  Jennifer L McCurtain; Adam J Gilbertsen; Clayton Evert; Bryan J Williams; Ryan C Hunter
Journal:  J Med Microbiol       Date:  2019-01-22       Impact factor: 2.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.